Breast Cancer | Oncology Today with Dr Neil Love: Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer

Research To Practice | Oncology Videos

Contenuto fornito da Dr Neil Love. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Dr Neil Love o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.

2M ago 54:03

MP4•Pagina principale dell'episodio

Featuring perspectives from Dr Sara A Hurvitz, including the following topics:

Case: A woman in her late 40s who received treatment for triple-negative breast cancer develops lung metastases 2 years later (0:00)
Clinical trials investigating TROP2-targeting antibody-drug conjugates (13:28)
Identifying and targeting HER2 in HER2 low-expressing disease (21:17)
Case: A woman in her early 50s who received treatment for Stage I breast cancer later develops multiple lesions similar to the original cancer (29:00)
Thresholds of HER2 expression and the efficacy of trastuzumab deruxtecan (T-DXd) (34:01)
Case: A woman in her late 50s receiving T-DXd for HER2-low metastatic breast cancer develops asymptomatic ground glass infiltrates in the lung (39:19)
Novel ADC strategies under investigation (48:22)

CME information and select publications

1423 episodi

#Science #Medicine #Cancer #Neillove #Oncology #Researchtopractice #Fitness #Dr Neil Love #Video